Novel isoxazoles which interact with brain cholinergic channel receptors have intrinsic cognitive enhancing and anxiolytic activities.

作者信息

Garvey D S, Wasicak J T, Decker M W, Brioni J D, Buckley M J, Sullivan J P, Carrera G M, Holladay M W, Arneric S P, Williams M

机构信息

Neuroscience Research Division, Abbott Laboratories, Abbott Park, Illinois 60064.

出版信息

J Med Chem. 1994 Apr 15;37(8):1055-9. doi: 10.1021/jm00034a002.

DOI:10.1021/jm00034a002

PMID:7909335

Abstract

摘要

相似文献

Novel isoxazoles which interact with brain cholinergic channel receptors have intrinsic cognitive enhancing and anxiolytic activities.

J Med Chem. 1994 Apr 15;37(8):1055-9. doi: 10.1021/jm00034a002.

(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.（S）-3-甲基-5-（1-甲基-2-吡咯烷基）异恶唑（ABT 418）：一种具有认知增强和抗焦虑活性的新型胆碱能配体：I. 体外特性研究

J Pharmacol Exp Ther. 1994 Jul;270(1):310-8.

Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties.

J Med Chem. 1997 Jan 31;40(3):385-90. doi: 10.1021/jm960233u.

(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.(S)-3-甲基-5-(1-甲基-2-吡咯烷基)异恶唑（ABT 418）：一种具有认知增强和抗焦虑活性的新型胆碱能配体：II. 体内特性研究

J Pharmacol Exp Ther. 1994 Jul;270(1):319-28.

Characterization of [3H]ABT-418: a novel cholinergic channel ligand.[3H]ABT-418的特性：一种新型胆碱能通道配体。

J Pharmacol Exp Ther. 1995 Jun;273(3):1434-41.

Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties.

Alzheimer Dis Assoc Disord. 1995;9 Suppl 2:50-61. doi: 10.1097/00002093-199501002-00009.

Biochemical characterization of the nicotinic cholinergic receptors in human brain: binding of (-)-[3H]nicotine.

J Neurochem. 1985 Aug;45(2):604-10. doi: 10.1111/j.1471-4159.1985.tb04029.x.

Application of [125I] (S)-5-iodonicotine, a new radioiodinated ligand, in the assay of nicotinic acetylcholine receptor binding in the brain.

Biol Pharm Bull. 1995 Nov;18(11):1463-6. doi: 10.1248/bpb.18.1463.

Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.3-（3-苯基异恶唑-5-基）亚甲基-1-氮杂双环与乙酰胆碱受体的结合亲和力。

Bioorg Med Chem Lett. 1999 Oct 4;9(19):2795-800. doi: 10.1016/s0960-894x(99)00477-1.

Cholinergic deafferentation enhances rat hippocampal pyramidal neuron responsiveness to locally applied nicotine.胆碱能去传入增强大鼠海马锥体神经元对局部应用尼古丁的反应性。

Brain Res. 1996 Jul 15;727(1-2):217-20. doi: 10.1016/0006-8993(96)00402-7.

引用本文的文献

Determinants for α4β2 vs. α3β4 Subtype Selectivity of Pyrrolidine-Based nAChRs Ligands: A Computational Perspective with Focus on Recent cryo-EM Receptor Structures.基于吡咯烷的烟碱型乙酰胆碱受体配体对 α4β2 与 α3β4 亚型选择性的决定因素：基于近期冷冻电镜受体结构的计算研究视角。

Molecules. 2021 Jun 12;26(12):3603. doi: 10.3390/molecules26123603.

Screening of Synthetic Isoxazolone Derivative Role in Alzheimer's Disease: Computational and Pharmacological Approach.筛选合成异恶唑酮衍生物在阿尔茨海默病中的作用：计算和药理学方法。

Neurochem Res. 2021 Apr;46(4):905-920. doi: 10.1007/s11064-021-03229-w. Epub 2021 Jan 24.

Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic.建立天然益智药：受天然益智药影响的近期分子增强作用。

Evid Based Complement Alternat Med. 2016;2016:4391375. doi: 10.1155/2016/4391375. Epub 2016 Aug 30.

1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.以异恶唑为可溶环氧化物水解酶抑制剂的1,3-二取代和1,3,3-三取代金刚烷基脲

Bioorg Med Chem Lett. 2015 Dec 1;25(23):5514-9. doi: 10.1016/j.bmcl.2015.10.066. Epub 2015 Oct 23.

Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test.烟碱型乙酰胆碱受体激动剂改善 5 -choice 连续操作测试中小鼠的警觉性。

Behav Brain Res. 2013 Mar 1;240:119-33. doi: 10.1016/j.bbr.2012.11.028. Epub 2012 Nov 29.

Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity.基于异恶唑醚骨架的新型 α4β2-烟碱型乙酰胆碱受体 (nAChR) 激动剂的鉴定，这些激动剂具有抗抑郁样活性。

J Med Chem. 2012 Jan 26;55(2):812-23. doi: 10.1021/jm201301h. Epub 2012 Jan 4.

Nicotinic agonists, antagonists, and modulators from natural sources.来自天然来源的烟碱激动剂、拮抗剂和调节剂。

Cell Mol Neurobiol. 2005 Jun;25(3-4):513-52. doi: 10.1007/s10571-005-3968-4.

Nicotinic acetylcholine receptor (nACh-R) agonist-induced changes in brain monoamine turnover in mice.烟碱型乙酰胆碱受体（nACh-R）激动剂诱导的小鼠脑单胺代谢变化。

Psychopharmacology (Berl). 1997 Feb;129(3):225-32. doi: 10.1007/s002130050184.

Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes.大鼠海马突触体中烟碱型自身受体的药理学特性

Neurochem Res. 1996 Sep;21(9):1141-8. doi: 10.1007/BF02532425.

Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist.尼古丁与新型烟碱激动剂ABT-418的比较药理学

Psychopharmacology (Berl). 1995 Aug;120(4):483-90. doi: 10.1007/BF02245822.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验